1-13 of 13
Enrique Ocio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor Cells (CTCs) in Smoldering and Active Multiple Myeloma (MM): Mechanism of Egression, Clinical Significance and Therapeutic Endpoints

Juan-José Garcés, Noemi Puig, Rosalinda Termini, María Teresa Cedena, Cristina Moreno, José J Pérez, Diego Alignani, Sarvide Sarai, Albert Oriol, Esther González Garcia, Fernando Escalante, Anna Sureda, Felipe De Arriba, Rafael Rios, Jose Maria Moraleda, Mercedes Gironella, Miguel T Hernández, Juan Jose Joan Bargay, Luis Palomera, Alberto Orfao, Evangelos Terpos, Albert Pérez, Tomas Jelinek, Alexia Suárez, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo M. Roccaro, Joaquin Martinez-Lopez, Juan Jose Lahuerta, Enrique Ocio, Laura Rosinol, Joan Bladé Creixenti, Maria-Victoria Mateos, Jesus San-Miguel, Bruno Paiva
Journal: Blood
Blood (2021) 138 (Supplement 1): 76.
https://doi.org/10.1182/blood-2021-146535
Published: 2021
Journal Articles

A Multi-Center, Phase 1b Study to Assess the Safety, Pharmacokinetics and Efficacy of Subcutaneous Isatuximab Plus Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Multiple Myeloma

Philippe Moreau, Gurdeep Parmar, Miles Prince, Enrique Ocio, Chatchada Karanes, Sumit Madan, Albert Oriol, Pierre Bories, Michel Delforge, Nashat Gabrail, Dorothee Semiond, Nan Jia, Sandrine Macé, Florence Suzan, Helgi van de Velde, Hang Quach
Journal: Blood
Blood (2021) 138 (Supplement 1): 2744.
https://doi.org/10.1182/blood-2021-147136
Published: 2021
Journal Articles

CC-92480, a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD) Agent, in Combination with Dexamethasone (DEX) and Bortezomib (BORT) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Phase 1/2 Study CC-92480-MM-002

Paul G. Richardson, Enrique Ocio, Noopur S. Raje, Tara Gregory, Darrell White, Albert Oriol, Irwindeep Sandhu, Marc-Steffen Raab, Richard LeBlanc, Cesar Rodriguez, Suzanne Trudel, Ralph Wäsch, Aurore Perrot, Nizar J. Bahlis, Zehua Zhou, Manisha Lamba, Michael Amatangelo, Tiziana Civardi, Jessica Katz, Paulo Maciag, Teresa Peluso, Meletios A. Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2731.
https://doi.org/10.1182/blood-2021-147812
Published: 2021
Journal Articles

Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd

Maria-Victoria Mateos, Joaquin Martinez Lopez, Paula Rodríguez-Otero, Veronica Gonzalez-Calle, Marta Sonia Gonzalez, Albert Oriol, Norma C. Gutierrez, Rafael Rios, Laura Rosinol, Miguel Angel Alvarez, Joan Bargay, Ana Pilar Gonzalez, Adrian Alegre, Fernando Escalante, Belén Iñigo, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro Hernández, Javier Lopez Jimenez, Aránzazu García Mateo, Marta Reinoso Segura, Enrique Ocio, Bruno Paiva, Noemi Puig, María Teresa Cedena, Joan Bladé, Juan Jose Lahuerta, Jesús F. San-Miguel
Journal: Blood
Blood (2021) 138 (Supplement 1): 1829.
https://doi.org/10.1182/blood-2021-148423
Published: 2021
Journal Articles

LocoMMotion: A Prospective, Non-Interventional, Multinational Study of Real-Life Current Standards of Care in Patients With Relapsed/Refractory Multiple Myeloma Who Received ≥3 Prior Lines of Therapy

Philippe Moreau, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michele Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W.C.J. Van de Donk, Enrique Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodriguez-Otero, Annemiek Broyl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M. Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesus San-Miguel, Pieter Sonneveld, Hermann Einsele, Maria-Victoria Mateos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3057.
https://doi.org/10.1182/blood-2021-146188
Published: 2021
Journal Articles

OP-106 Horizon — Melflufen Therapy for RRMM Patients Refractory to Daratumumab and/or Pomalidomide; Updated Results and First Report on PFS

Paul Richardson, Enrique Ocio, MD, Albert Oriol, MD, Alessandra Larocca, MD, Paula Rodriguez Otero, MD, Jan Moreb, MD, Joan Bladé, MD, Hani Hassoun, MD, Michele Cavo, MD, Adrián Alegre, MD, Amitabha Mazumder, MD, Christopher Maisel, MD, Agne Paner, MD, Nashat Gabrail, MD, Jeffrey A Zonder, MD, Dharminder Chauhan, PhD, Johan Harmenberg, MD, Sara Thuresson, MSc, Hanan Zubair, MSc, Maria-Victoria Mateos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 600.
https://doi.org/10.1182/blood-2018-99-113095
Published: 2018
Journal Articles

The OP-104 Anchor Study: A Phase 1/2 Study of Safety and Efficacy of Melflufen and Dexamethasone in Combination with Either Bortezomib or Daratumumab in Patients with Rrmm; First Report on Phase 1 Data

Ludek Pour, MD, Miquel Granell, MD, Roman Hajek, MD PhD, Albert Oriol, MD, Yvonne Efebera, MD, Jacques Delaunay, MD, Katell Le Du, MD, Jean-Richard Eveillard, MD, Lionel Karlin, MD, Vladimir Maisnar, MD, Joaquin Martinez Lopez, MD, Maria-Victoria Mateos, MD PhD, Jan Moreb, MD, Vincent Ribrag, MD, Paul Richardson, Jan Straub, MD, Catriona Byrne, RN, Christian Jacques, MD, Hanan Zubair, MSc, Enrique Ocio, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1967.
https://doi.org/10.1182/blood-2018-99-112983
Published: 2018
Journal Articles

Novel Ex Vivo Assay Measures Drug-Induced Depletion of Hematopoietic Progenitors As an Estimate of Hematotoxicity

Daniel Primo, PhD, Joan Ballesteros, PhD, Antonio Jimenez, MD, Ataulfo Gonzalez, MD, Miguel Hernandez, MD, Raul Cordoba, MD, Yolanda González, MD, Hernan Jose Moreno, MD, Alicia Bailen, MD, Jesus Martin, MD, Anabelle Chinea, MD, Asuncion Etxeveste, MD, Jose Mariano Hernandez, MD, Albert Oriol, MD, Jaime Perez de Oteiza, MD, Luis Palomera, Cristina Encinas, MD, Felipe Prosper, MD, Rebeca Iglesias, MD, Laura Rosiñol, MD PhD, Alicia Robles, Julian Gorrochategui, Veronica Garcia, Pilar Hernandez, PhD, Enrique Ocio, MD, Joaquin Martinez, MD
Journal: Blood
Blood (2014) 124 (21): 5785.
https://doi.org/10.1182/blood.V124.21.5785.5785
Published: 2014
Journal Articles

Effect of Mesenchymal Stem Cells on the Viability, Proliferation and Differentiation of B Lymphocytes.

Soraya Tabera, Jose A. Perez-Simon, Maria Diez-Campelo, Luis I. Sanchez-Abarca, Belen Blanco, Ana Benito, Enrique Ocio, Fermin M. Sanchez-Guijo, Consuelo Canizo, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 3880.
https://doi.org/10.1182/blood.V110.11.3880.3880
Published: 2007
Journal Articles

International Prognostic Scoring System (IPSS) for Waldenström’s Macroglobulinemia (WM).

Pierre Morel, Alain Duhamel, Paolo Gobbi, Meletios Dimopoulos, Madhav Dhodapkar, Jason McCoy, Enrique Ocio, Ramon Garcia-Sanz, Steven Treon, Veronique Leblond, Robert Kyle, Bart Barlogie, Giampaolo Merlini
Journal: Blood
Blood (2006) 108 (11): 127.
https://doi.org/10.1182/blood.V108.11.127.127
Published: 2006
Journal Articles

Akt Inhibitor Perifosine-Induced Cytotoxicity Is Associated with Significant Downregulation of Survivin in Human Multiple Myeloma (MM) Cells.

Teru Hideshima, MD, PhD, Hiroshi Yasui, MD, PhD, Laurence Catley, MD, Noopur Raje, MD, Dharminder Chauhan, PhD, Kenji Ishitsuka, MD, PhD, Klaus Podar, MD, PhD, Constantine Mitsiades, MD, PhD, Yu-Tzu Tai, PhD, Sonia Vallet, MD, Tanyel Kizitepe, PhD, Enrique Ocio, MD, PhD, Hiroshi Ikeda, MD, PhD, Yutaka Okawa, MD, PhD, Hiromasa Hideshima, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2006) 108 (11): 3410.
https://doi.org/10.1182/blood.V108.11.3410.3410
Published: 2006
Journal Articles

A Waldenström’s Macroglobulinemia Case with Functional Class Switch Recombination.

Patricia Martín-Jiménez, Ramón García-Sanz, Enrique Ocio, María E. Sarasquete, Ana Balanzategui, Miguel Alcoceba, María C. Chillón, Carlos Santamaría, J.F. San Miguel, Marcos González
Journal: Blood
Blood (2006) 108 (11): 4283.
https://doi.org/10.1182/blood.V108.11.4283.4283
Published: 2006
Journal Articles

Perifosine, an Oral Bioactive Novel Akt Inhibitor, Induces In Vitro and In Vivo Antitumor Activity in Waldenstrom Macroglobulinemia.

Xavier Leleu, MD, Xiaoying Jia, Anne-Sophie Moreau, MD, Evdoxia Hatjiharisi, MD, Hai Ngo, Garrett O’Sullivan, Daisy Moreno, Tanyel Kiziltepe, PhD, Enrique Ocio, MD, Allen Ho, MD, Thierry Facon, MD, Steven Treon, MD, Teru Hideshima, MD, Kenneth Anderson, MD, Irene Ghobrial, MD
Journal: Blood
Blood (2006) 108 (11): 2488.
https://doi.org/10.1182/blood.V108.11.2488.2488
Published: 2006